Traditional cancer genomic testing produces a one-time report. As new therapies are approved, trials open, and biomarkers are identified, the report does not update. GenTraceDx secured ~$6M in GAPP funding to change this: buff.ly/1d2nzu8 @bcgsc.ca @genomecanada.ca @genomebc.bsky.social #Genomics
Canadian Team Advances Breakthrough "Living" Cancer Diagnostic Platform Following National GAPP Funding
/CNW/ - Genetrack Biolabs, working in partnership with Canada's Michael Smith Genome Sciences Centre as part of a landmark research–industry collaboration, has...
buff.ly